BERKELEY HEIGHTS, N.J.--(BUSINESS WIRE)--Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC)(NASDAQ:CYCCP) announced today financial and operating results for the first quarter of 2008. The Company’s net loss for the quarter was $6.3 million or $0.31 per share. As of March 31, 2008, the company had $49.0 million in cash, cash equivalents and short-term investments.
